Concepedia

Author

Hirohiko Shibayama

The University of OsakaORCID

Also Known As

Aya Nakaya, H Shibayama, H. Shibayama, HIROHIKO SHIBAYAMA, Hideo Yagi, Hirohiko Shibayama, Hirokazu Tanaka, Hiromitsu Shibayama, Kanakura, Y, Katsumichi Fujimaki

257

Publications

4.8K

Citations

33

H-Index

101

Concepts

All Affiliations

The University of OsakaNational Hospital OrganizationOsaka University HospitalKyoto UniversityKindai University
HS

About

Hirohiko Shibayama is an author at The University of Osaka specializing in medicine, hematology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

41

1.2K

2

Health Sciences

12

15

492

3

Natural Sciences

4

4

87

4

Public Health

1

1

22

5

Allergy

1

1

30

Hirohiko Shibayama

×

88

Publications

4.3K

Citations

32

H-Index

YearCitations

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro,

The Lancet

2018

707

Genetic Variants in C5 and Poor Response to Eculizumab

Jun‐ichi Nishimura, Masaki Yamamoto, Shin Hayashi,

New England Journal of Medicine

2014

392

Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells

Yusuke Satoh, Itaru Matsumura, Hirokazu Tanaka,

Journal of Biological Chemistry

2004

160

Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability

Charlie Mantel, Ying Guo, Man Ryul Lee,

Blood

2007

140

Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis

Hirohiko Shibayama, Emi Takai, Itaru Matsumura,

The Journal of Experimental Medicine

2004

119

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

Masaya Okada, Jun Imagawa, Hideo Tanaka,

Clinical Lymphoma Myeloma & Leukemia

2018

116

Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells

Hanako Daino, Itaru Matsumura, Koji Takada,

Blood

2000

114

Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor–induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration

Shuji Ueda, Masao Mizuki, Hirokazu Ikeda,

Blood

2002

112

Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse

Saiko Kurosawa, T Yamaguchi, S Miyawaki,

Haematologica

2010

107

Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial

Shinya Kimura, Jun Imagawa, Kazunori Murai,

The Lancet Haematology

2020

100

Page 1